Healthcare provider profile · identity verified

Ryan Matthew Pickell, M.D.

Internal Medicine · INDIANAPOLIS, IN · NPI 1578943460

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	431	57
Gabapentin	Gabapentin	275	38
Levothyroxine Sodium	Levothyroxine Sodium	228	29
Omeprazole	Omeprazole	225	34
Amlodipine Besylate	Amlodipine Besylate	219	28
Trazodone Hcl	Trazodone Hcl	199	29
Pantoprazole Sodium	Pantoprazole Sodium	187	26
Torsemide	Torsemide	184	21
Potassium Chloride	Potassium Chloride	178	27
Furosemide	Furosemide	170	31
Eliquis	Apixaban	155	23
Metformin Hcl	Metformin Hcl	152	18
Famotidine	Famotidine	145	15
Lisinopril	Lisinopril	139	20
Metoprolol Succinate	Metoprolol Succinate	134	25
Metoprolol Tartrate	Metoprolol Tartrate	128	14
Sertraline Hcl	Sertraline Hcl	122	18
Buspirone Hcl	Buspirone Hcl	120	14
Duloxetine Hcl	Duloxetine Hcl	116	17
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	98	15
Escitalopram Oxalate	Escitalopram Oxalate	98	12
Clozapine	Clozapine	91	suppressed
Allopurinol	Allopurinol	82	suppressed
Losartan Potassium	Losartan Potassium	80	13
Spironolactone	Spironolactone	80	11
Fluoxetine Hcl	Fluoxetine Hcl	79	suppressed
Carvedilol	Carvedilol	78	11
Tamsulosin Hcl	Tamsulosin Hcl	74	15
Mirtazapine	Mirtazapine	67	suppressed
Olanzapine	Olanzapine	66	suppressed
Topiramate	Topiramate	65	suppressed
Clopidogrel	Clopidogrel Bisulfate	60	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	59	suppressed
Fluticasone Propionate	Fluticasone Propionate	58	17
Jardiance	Empagliflozin	57	suppressed
Bupropion Xl	Bupropion Hcl	56	suppressed
Ezetimibe	Ezetimibe	54	suppressed
Glipizide	Glipizide	54	suppressed
Pravastatin Sodium	Pravastatin Sodium	54	suppressed
Ropinirole Hcl	Ropinirole Hcl	53	suppressed
Aripiprazole	Aripiprazole	51	suppressed
Levetiracetam	Levetiracetam	50	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	49	suppressed
Lamotrigine	Lamotrigine	48	suppressed
Baclofen	Baclofen	43	suppressed
Breo Ellipta	Fluticasone/Vilanterol	43	13
Albuterol Sulfate Hfa	Albuterol Sulfate	42	30
Midodrine Hcl	Midodrine Hcl	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	12
Montelukast Sodium	Montelukast Sodium	41	suppressed
Simvastatin	Simvastatin	39	suppressed
Donepezil Hcl	Donepezil Hcl	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	38	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	38	suppressed
Amiodarone Hcl	Amiodarone Hcl	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Divalproex Sodium	Divalproex Sodium	31	suppressed
Fenofibrate	Fenofibrate	31	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Doxepin Hcl	Doxepin Hcl	30	suppressed
Hydrocortisone	Hydrocortisone	29	suppressed
Valsartan	Valsartan	28	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Benztropine Mesylate	Benztropine Mesylate	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Glimepiride	Glimepiride	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Ozempic	Semaglutide	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Myrbetriq	Mirabegron	24	suppressed
Restasis	Cyclosporine	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Trulicity	Dulaglutide	22	suppressed
Gemtesa	Vibegron	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Invega Sustenna	Paliperidone Palmitate	20	suppressed
Latanoprost	Latanoprost	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Risperidone	Risperidone	20	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Divalproex Sodium Er	Divalproex Sodium	18	suppressed
Loperamide	Loperamide Hcl	18	13
Meclizine Hcl	Meclizine Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Roflumilast	Roflumilast	16	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Digoxin	Digoxin	14	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	14	suppressed
Primidone	Primidone	14	suppressed
Acetazolamide	Acetazolamide	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Rexulti	Brexpiprazole	13	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Paliperidone Er	Paliperidone	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ramelteon	Ramelteon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error